ref : 9699
Year of mfg. : 2024
Country : France
Available
We sell only in Africa
Free delivery Abidjan
New equipment
Introducing a new era in clinical tonometry – now with Quick Measure
Key features
NEW! Quick Measure - A fast measuring mode for challenging patients
200-degree position freedom
Suitable for all patients
Consistant and accurate readings
No anesthetic drops
Improved probe control
No calibration
iCare IC200 is the most versatile tonometer in iCare’s product portfolio. This flagship device now offers a Quick Measure feature to capture intraocular pressure (IOP) measurements faster and easier than before. With 200 degrees of positional freedom, the iCare IC200 can measure IOP whether the patient is supine, reclined or seated.
Extensive flexibility in positioning is especially useful in clinical, surgical or emergency settings when the patient’s eye pressure needs to be measured regardless of the patient’s position.
You still get all the benefits of iCare’s patented rebound technology eliminating the need for a puff of air or anesthetic drops. The exam is non-invasive, accurate, comfortable for the patients and easy to perform for the operator.
Direct sale
4
Year of mfg.
-
Available
Country
France
Buy now 6 500 €
Direct sale
2
Year of mfg.
2019
Available
Country
South Africa
Buy now 1 000 €
Direct sale
1
Year of mfg.
2015
Available
Country
France
Buy now 4 600 €
There was an error when considering the interest of the product. Please try or contact the support.
Your partnership request has been sent by email to the OPHTAZON team.
Your partnership request has been sent by email to the OPHTAZON team.
Your application for a partnership was not successful. Please try again or contact the support.
HOME
sales@ophtazon.com / +33 141 515 490
INTERNATIONAL SALES MANAGER
M. Sadreddine MEHRI
sadreddine.mehri@ophtazon.com / +33 6 08 84 07 42
TECHNICAL & SALES MANAGER IVORY COAST
M. Khaled SELLAMI
khaled.sellami@ophtazon.com / +225 07 68 46 36 14
Nous utilisons différentes technologies pour optimiser votre expérience utilisateur.
Merci de cliquer sur le bouton pour donner votre accord.
Vous souhaitez en savoir plus ? Cliquez ici